Pharmacokinetic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults
An epinephrine nasal spray (ENS) is under development for treatment of anaphylaxis. This analysis compared the pharmacokinetic (PK) profile of 13.2 mg ENS with that of the standard of care 0.3 mg intramuscular (IM) epinephrine autoinjector.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Matthew Greenhawt, David Bernstein, Michael Blaiss, Lawrence Dubuske, David Fleischer, Jay Lieberman, John Oppenheimer, David Dworaczyk Source Type: research